Pfizer Inc. X Hesabı İstatistikleri

X Hesabı

http://x.com/pfizer_news

Son Kontrol : 14.12.2025

Takipçisi 33.772

Takip Edilen 762

Sektör

Tweetler	Beğeni	Retweet	Etkileşim
At #SABCS25 and published in @JCO_ASCO, we’re sharing Phase 3 progression-free survival data for our tyrosine kinase inhibitor as part of first-line maintenance treatment for patients with HER2+ metastatic #BreastCancer. Learn more:...	1	0	%0,00
At #SABCS25 we’re sharing 28 abstracts including Phase 3 data in HER2+ disease, insights supporting our late-stage HR+, HER2- pipeline, and real-world evidence, as we work to advance care and deliver meaningful progress for people with metastatic...	0	0	%0,00
At #ASH25, we’re excited to share positive results from our Phase 3 study in people with hemophilia A or B with inhibitors. Learn more about the data presented, which were simultaneously published in @BloodPortfolio: https://t.co/QuSsBkPS9h...	4	2	%0,04

Tweetler	Tarih	Beğeni	Retweet	Etkileşim

Tweetler	Tarih	Beğeni	Retweet	Yorum	Görüntülenme

Takipçi : 33.772

Web sitesi : https://t.co/h3cXbmQVgY

Kullanıcı : pfizer_news

Tanıtım :

Sayfa ile ilgili istek ve şikayetleriniz için aşağıdaki formu kullanabilirsiniz.